| Literature DB >> 33194015 |
Dongzi Lin1,2, Qiankun Liu1, Wei Wang2, Yanyun Li1, Yumei Li3, Bihua Lin1, Ziyu Ye1, Juan Huang1, Xiaolin Yu3, Yinwen Chen3, Yuezhi Mei3, Minyuan Huang1, Weiqin Yang1, Jie Zhou2, Xinguang Liu1, Jincheng Zeng1.
Abstract
Tuberculosis (TB) immunity is affected by complex immune regulation processes, which involve various immune cells, immune molecules, and cytokines. Here, we evaluated the expression of B12, CD272 and miR-16 in peripheral blood mononuclear cells (PBMC) of patients with active pulmonary tuberculosis. The results showed that monocytes expressing CD272 or B12 were down-regulated in patients with tuberculosis. The expression of B12 and CD272 in T cells and monocytes is related to tuberculosis. In TB patients, the up-regulation of miR-16 was negatively correlated with B12 mRNA expression, miR-16 was mainly expressed in CD14+ monocytes, and CD272 mRNA was mainly expressed in CD19+ B cells. It is worth noting that the overexpression of miR-16 inhibits the expression of CD272 and B12 in monocytes of TB patients. After BCG stimulation, miR-16 expression of CD14+ monocytes was up-regulated and B12 mRNA and CD272 mRNA expressions were down-regulated in TB patients. Finally, we found that miR-16 may participate in the TB immunization process through targeted regulation of B12 expression. These studies indicate that the expression of B12, CD272 and miR-16 in PBMC may be related to tuberculosis. AJTREntities:
Keywords: B12; CD272; Tuberculosis; miR-16; peripheral blood mononuclear cells
Year: 2020 PMID: 33194015 PMCID: PMC7653578
Source DB: PubMed Journal: Am J Transl Res ISSN: 1943-8141 Impact factor: 4.060